It was shown that auto-antibodies against IFNα and IFNω (and not IFNβ) were present in up to 20% of life-threatening COVID-19 infections and COVID-19 deaths (in comparison to less than 5% of healthy controls), and were more common in elderly male patients [83,84,85,86,87]. This evidence concerns the gene IFNB1 and COVID-19.